May 12, 2020 8:00 am EDT Enzo Announces Issuance of U.S. Patent for Methods of Producing Monoclonal Antibodies Against Osteoporosis Drug Target Sclerostin
Apr 29, 2020 8:00 am EDT Enzo Announces Issuance of U.S. Patent for Methods of Using Proprietary Compound SK1-I in Patients; Exploring Options for Development as a Potential Treatment for COVID-19
Apr 23, 2020 8:00 am EDT Enzo Biochem Launches Proprietary COVID-19 Diagnostic Test Under FDA’s Emergency Use Authorization
Mar 24, 2020 7:30 am EDT Enzo Biochem’s Clinical Labs Subsidiary Launches Drive-Through Facility to Provide COVID-19 Testing on Long Island
Mar 6, 2020 8:00 am EST Enzo Biochem’s Full Service Clinical Laboratory to Launch Coronavirus (COVID-19) Testing Services Next Week
Mar 3, 2020 10:00 am EST Enzo Biochem Schedules Teleconference to Discuss Second Quarter 2020 Results Friday, March 6, 2020 at 8:30 AM E.T.
Feb 25, 2020 9:59 am EST Enzo Biochem Announces Preliminary Results of Voting at Annual Shareholder Meeting
Feb 19, 2020 8:30 am EST Enzo Biochem Reports Publication of Study Detailing Promising Activity of Drug Candidate SK1‑I in a Model of Lupus
Feb 11, 2020 8:30 am EST Enzo Biochem Announces Significant Milestone with Approval of Proprietary GenFlex Platform
